Dialysis News and Research

Latest Dialysis News and Research

DaVita signs major tender to treat dialysis patients in Saudi Arabia

DaVita, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, today announced it has signed a major tender from the Kingdom of Saudi Arabia's Ministry of Health to treat half of the approximately 10,000 dialysis patients currently under the Ministry's care.

17 Feb 2014

Study looks at effects of exercise on heart health in patients with chronic kidney disease

A Leicester doctor has become the first renal physician in the country to be awarded the National Institute for Health Research (NIHR) Clinician Scientist Award. The fellowship, worth more than £1 million, will fund a five-year study into the effects of exercise on heart disease in patients with chronic kidney disease who are on dialysis.

11 Feb 2014

DaVita donates $1.2M to charities across United States

DaVita, the kidney care division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, announced that its teammates donated $1.2 million to charities in more than 1,100 communities across the United States as part of the "DaVita Way of Giving."

10 Feb 2014

Patients who experience abrupt kidney injury following surgery have increased risk of heart problems

Patients who experience abrupt kidney injury following surgery have an increased risk of later developing heart problems, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

7 Feb 2014

Invacare reports net loss per share of $0.19 in fourth quarter 2013

Invacare Corporation today announced its financial results for the quarter and year ended December 31, 2013.

6 Feb 2014

New prospective payment system contributes to improved patient choice, quality of care and costs

AcademyHealth today awarded its Health Services Research (HSR) Impact Award to work that contributed to the development of a prospective payment system that contributed to improved patient choice and quality of care, and reduced costs in the treatment of End Stage Renal Disease (ESRD).

4 Feb 2014

Minimally invasive robotic surgery: A safe alternative to traditional open surgery

A collaboration of surgeons at Henry Ford Hospital and Medanta Hospital in India successfully transplanted kidneys into 50 recipients using an innovative robot-assisted procedure in which the organ is cooled with sterile ice during the operation.

24 Jan 2014

Alexion's Soliris gets FDA orphan drug designation for DGF prevention in renal transplant patients

Alexion Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted an orphan drug designation to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of delayed graft function in renal transplant patients.

21 Jan 2014

Hope in sight for sufferers of chronic renal disease

Miss M. spends around 15 hours a week in hospital. Her renal functions are limited, and her kidneys are no longer able to filter toxins from her blood. She is a dialysis patient, forced to rely on this artificial blood purification treatment that, although essential, greatly impairs her quality of life. She has to make three trips a week to the dialysis clinic and going away for longer than a few days is almost out of the question. And Miss M. is no exception: In Germany alone, over six million people suffer from some form of chronic renal disease.

17 Jan 2014

Argon gets FDA clearance to market OptionELITE IVC filter over-the-wire delivery technique

Argon Medical Devices, Inc. announced today that the company has received clearance from the US Food and Drug Administration to begin marketing the OptionELITE retrievable inferior vena cava filter with a new over-the-wire delivery technique.

16 Jan 2014

New study examines factors that may lead to end stage renal disease

About 33 percent of people with type 2 diabetes suffer kidney damage that progresses to end stage renal disease, at which point they require either dialysis or kidney transplantation. Scientists have thought that this kidney disease is driven by damage to the glomeruli, blood vessels in the kidney, which spill the protein albumin into the urine. Current treatments targeting the resulting "albuminuria" do not prevent kidney failure.

15 Jan 2014

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

13 Jan 2014

Proteon's PRT-201 gets orphan drug designation for prevention of arteriovenous access dysfunction

Proteon Therapeutics, Inc., a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, today announced that its lead product, PRT-201, has received orphan drug designation in the European Union for the prevention of arteriovenous access dysfunction in hemodialysis patients.

9 Jan 2014

Shield Therapeutics reports positive top-line data from pivotal Phase 3 programme of ST10

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces strongly positive top-line data from the pivotal Phase 3 programme of ST10 for the treatment of iron deficiency anaemia in inflammatory bowel disease.

7 Jan 2014

Blood conservation strategy during AVR can reduce costs, complications

Incorporating a blood conservation strategy (BCS) during aortic valve replacement (AVR) can reduce the likelihood of transfusion-related complications, as well as reduce blood-product utilization, according to a study in the January 2014 issue of The Annals of Thoracic Surgery.

2 Jan 2014

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

Otsuka Pharmaceutical Co., Ltd. announced today that the European Medicines Agency (EMA) has accepted the submission of a marketing authorisation application (MAA) for the potential approval of tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD).

27 Dec 2013

ICSA awards 2014 ONC HIT certification to Acumen EHR system

Acumen Physician Solutions, a market leading EHR and practice management system for nephrology, announced today that its product Acumen EHR, Version 7.0 is compliant with the ONC 2014 Edition criteria and was certified as a Complete EHR.

27 Dec 2013

Holiday reads: Squabbling families, the psychology of Santa, holiday stress and chocolate chip cookies

[T]his time of year the Internet is ripe with lists on how to avoid or mitigate family conflicts. At big gatherings, familiarity may not always breed contempt, but it sure can breed festering emotional wounds. Leonard Felder, a Los Angeles psychologist, has found that about three-quarters of us have at least one family member who annoys us. But why is it that the same minor jabs and annoying tics that are harmless coming from friends prompt epic screaming matches when uttered by relatives? ... Here are four theories as to why our families drive us nuts, and it would be nice of you to pay attention for once in your life (Olga Khazan, 12/23).

24 Dec 2013

Baxter’s VIVIA hemodialysis system receives CE marking in Europe

Baxter International Inc. today announced completion of CE marking in Europe for the VIVIA hemodialysis system, designed to deliver more frequent, extended duration, short daily or nocturnal home HD therapy, known as High Dose HD therapy.

From Baxter International Inc. 20 Dec 2013

Atara Biotherapeutics secures $38.5M in initial closings under Series B financing

Atara Biotherapeutics, Inc., a drug development company with a focus on innovative therapies for patients with debilitating diseases, announced today that it has secured $38.5 million in initial closings under its Series B financing. In this round, investors Amgen Ventures, Celgene Corporation, and EcoR1 Capital, joined existing investors Alexandria Venture Investments, DAG Ventures, Domain Associates, and Kleiner Perkins Caufield & Byers.

17 Dec 2013

Dialysis News and Research

Latest Dialysis News and Research

DaVita signs major tender to treat dialysis patients in Saudi Arabia

Study looks at effects of exercise on heart health in patients with chronic kidney disease

DaVita donates $1.2M to charities across United States

Patients who experience abrupt kidney injury following surgery have increased risk of heart problems

Invacare reports net loss per share of $0.19 in fourth quarter 2013

New prospective payment system contributes to improved patient choice, quality of care and costs

Minimally invasive robotic surgery: A safe alternative to traditional open surgery

Alexion's Soliris gets FDA orphan drug designation for DGF prevention in renal transplant patients

Hope in sight for sufferers of chronic renal disease

Argon gets FDA clearance to market OptionELITE IVC filter over-the-wire delivery technique

New study examines factors that may lead to end stage renal disease

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

Proteon's PRT-201 gets orphan drug designation for prevention of arteriovenous access dysfunction

Shield Therapeutics reports positive top-line data from pivotal Phase 3 programme of ST10

Blood conservation strategy during AVR can reduce costs, complications

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

ICSA awards 2014 ONC HIT certification to Acumen EHR system

Holiday reads: Squabbling families, the psychology of Santa, holiday stress and chocolate chip cookies

Baxter’s VIVIA hemodialysis system receives CE marking in Europe

Atara Biotherapeutics secures $38.5M in initial closings under Series B financing

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in